To examine whether our selective clones could selectively inhibit the activity of MMP14 in a cancer cell model, we performed a gelatin zymography assay with U87-malignant glioma (U87MG) cells, which naturally express high levels of MMP14, MMP9 and MMP2 [70, 72, 73]. Here, MMP9 is linked to malignant glioma.